ImpediMed (IPD) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period “Accelerate Action” to boost women’s leadership in Aussie healthcare sectorMarch 7, 2025 | msn.comHealth Check: Percheron ‘closes the book’ on failed childhood rare disease programFebruary 6, 2025 | msn.comImpediMed Secures $15M Growth Capital to Drive ExpansionFebruary 5, 2025 | tipranks.comImpediMed (ASX:IPD) investors are sitting on a loss of 72% if they invested three years agoFebruary 5, 2025 | finance.yahoo.comImpediMed Limited Reports Director’s Share AcquisitionJanuary 31, 2025 | tipranks.comImpediMed Leads Our Trio Of ASX Penny Stock HighlightsJanuary 9, 2025 | finance.yahoo.comImpediMed Limited Increases Director’s ShareholdingDecember 25, 2024 | markets.businessinsider.comImpediMed Alters Director’s Stock Holdings StrategyDecember 24, 2024 | markets.businessinsider.comImpedimed Director Boosts Shareholding with Fee ConversionDecember 24, 2024 | markets.businessinsider.com3 ASX Penny Stocks With Market Caps Larger Than A$30MDecember 9, 2024 | uk.finance.yahoo.comWe Think ImpediMed (ASX:IPD) Needs To Drive Business Growth CarefullyDecember 6, 2024 | uk.finance.yahoo.comImpediMed Limited Aims to Set New Standard of CareNovember 20, 2024 | markets.businessinsider.comImpediMed Limited Focuses on Commercial Growth StrategyNovember 19, 2024 | markets.businessinsider.comImpediMed Limited’s AGM Resolutions Signal Strategic GrowthNovember 19, 2024 | markets.businessinsider.comImpediMed Limited Showcases Innovations at Bell PotterNovember 18, 2024 | markets.businessinsider.comImpedimed Limited Issues Shares to ExecutivesNovember 4, 2024 | markets.businessinsider.comScott Power: Which ASX health stocks reaffirm FY25 guidance?October 25, 2024 | msn.comImpediMed Limited Presents at Major ConferenceOctober 24, 2024 | markets.businessinsider.comHealth Check: Control Bionics eyes 20pc revenue growth and ‘near term’ profitabilityOctober 10, 2024 | msn.comMarket Highlights: Fed hints at more rate cuts, gold hits highs, and all eyes on RBA todaySeptember 24, 2024 | msn.comHealthInvest 2024: The biotech sector looks in rude health, judging by these five ASX innovatorsSeptember 23, 2024 | msn.comImpediMed Limited (IPD.XA)September 23, 2024 | finance.yahoo.comQ2 2024 ImpediMed Ltd Activities Report Call TranscriptSeptember 14, 2024 | gurufocus.comHalf Year 2024 ImpediMed Ltd Earnings Call TranscriptSeptember 14, 2024 | gurufocus.comQ3 2024 ImpediMed Ltd Activities Report Call TranscriptSeptember 14, 2024 | gurufocus.comImpediMed Ltd Ordinary Shareholders Meeting TranscriptSeptember 14, 2024 | gurufocus.comFull Year 2024 ImpediMed Ltd Earnings Call TranscriptSeptember 14, 2024 | gurufocus.comImpedimed Ltd (ASX:IPD) Q4 2024 Earnings Call Transcript Highlights: Strong Core Business ...September 14, 2024 | gurufocus.comImpedimed Ltd (ASX:IPD) Q2 2024 Earnings Call Transcript Highlights: Key Takeaways and ...September 14, 2024 | gurufocus.comScoPo’s Powerplays: ASX health stocks fall in ‘lacklustre’ weekSeptember 6, 2024 | msn.comAugust Health Winners: LTR Pharma, Control Bionics lead sector at the ‘cusp of an extraordinary era’September 3, 2024 | msn.comImpedimed Ltd (IPD)September 3, 2024 | investing.comHealthInvest 2024 set to show off latest ASX healthcare innovatorsAugust 25, 2024 | msn.comMontana asbestos clinic seeks to reverse $6M in fines, penalties over false claimsAugust 21, 2024 | msn.comRising prices will prolong America's home-affordability crisis with 89% of the market still overvalued, Fitch saysAugust 21, 2024 | msn.comInvestors in ImpediMed (ASX:IPD) have unfortunately lost 74% over the last yearAugust 21, 2024 | finance.yahoo.comImpediMed's (ASX:IPD) investors will be pleased with their notable 72% return over the last yearMarch 14, 2024 | finance.yahoo.comSkin in the game: Which ASX director is betting on a lithium recovery?March 11, 2024 | msn.comImpedimed Stock (OTC:IPDQF) Dividends: History, Yield and DatesFebruary 26, 2024 | benzinga.comHow the experts are investing in healthcare-related AI and biotechFebruary 20, 2024 | msn.comScoPo’s Powerplays: ASX health stocks tumble as CSL bleeds after Phase III trial misses endpointFebruary 16, 2024 | msn.comImpedimed Ltd IPDFebruary 3, 2024 | morningstar.comMarket Highlights: Wall Street sentiment remains high, 9 most innovative firms, and 5 small caps to watch todayNovember 19, 2023 | msn.com2 ASX All Ords shares tumbling following leadership shakeupsNovember 19, 2023 | fool.com.auScoPo’s Powerplays: Who fancies 22 minutes of exercise? And ASX health stocks are up (finally)November 3, 2023 | msn.comImpediMed LimitedOctober 21, 2023 | afr.comInvesting in ImpediMed (ASX:IPD) a year ago would have delivered you a 146% gainOctober 6, 2023 | finance.yahoo.comAnalysts Expect Breakeven For ImpediMed Limited (ASX:IPD) Before LongSeptember 1, 2023 | finance.yahoo.comThe IPD Group Limited (ASX:IPG) Annual Results Are Out And Analysts Have Published New ForecastsAugust 29, 2023 | finance.yahoo.comHere's Why We're Watching ImpediMed's (ASX:IPD) Cash Burn SituationJuly 17, 2023 | finance.yahoo.com Remove Ads Get ImpediMed News Delivered to You Automatically Sign up to receive the latest news and ratings for IPD and its competitors with MarketBeat's FREE daily newsletter. Email Address IPD Media Mentions By Week IPD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IPD News Sentiment▼0.000.64▲Average Medical News Sentiment IPD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IPD Articles This Week▼01▲IPD Articles Average Week Remove Ads Get ImpediMed News Delivered to You Automatically Sign up to receive the latest news and ratings for IPD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Hamilton Thorne News Stratec News MaxCyte News Titan Medical News EKF Diagnostics News Quipt Home Medical News Creo Medical Group News Theralase Technologies News Novacyt News VentriPoint Diagnostics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:IPD) was last updated on 4/7/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImpediMed Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share ImpediMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
